AUPH - Aurinia Pharmaceuticals Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.60
DETAILS
HIGH:
$16.00
LOW:
$6.00
MEDIAN:
$13.00
CONSENSUS:
$12.60
DOWNSIDE:
20.28%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,572,983 | $23.3M | 0.0% | +40,710 | INCREASED |
| Greenblatt | 168,598 | $2.5M | 0.0% | +41,211 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-04 | Johnson Craig A | director | A-Award | 23,931 | $15.67 | $375K |
| 2026-06-04 | Goetz Kathleen | director | A-Award | 23,931 | $15.67 | $375K |
| 2026-06-04 | Nova Tina Susan | director | A-Award | 23,931 | $15.67 | $375K |
| 2026-06-04 | Bailey Jeffrey Allen | director | A-Award | 23,931 | $15.67 | $375K |
| 2026-06-02 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | BUY | 206,005 | $15.28 | $3.1M |
| 2026-06-01 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | BUY | 99 | $15.34 | $2K |
| 2026-06-01 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | BUY | 343,521 | $15.28 | $5.2M |
| 2026-05-29 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | BUY | 262,682 | $15.31 | $4.0M |
| 2026-05-29 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | BUY | 2,299 | $15.35 | $35K |
| 2026-06-02 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | J-Other | 10,000 | $15.00 | $150K |
| 2026-05-18 | Hearne Michael S | officer: Chief Financial Officer | A-Award | 70,230 | $15.28 | $1.1M |
| 2026-05-18 | Hearne Michael S | officer: Chief Financial Officer | A-Award | 116,144 | -- | -- |
| 2026-05-18 | Cole Ryan | officer: Chief Operating Officer | A-Award | 116,144 | -- | -- |
| 2026-05-18 | Cole Ryan | officer: Chief Operating Officer | A-Award | 70,230 | $15.28 | $1.1M |
| 2026-05-18 | Robertson Stephen P. | officer: Chief Legal Officer | A-Award | 115,541 | -- | -- |
| 2026-03-23 | Hearne Michael S | officer | ? | -- | -- | -- |
| 2026-03-23 | Cole Ryan | officer | ? | -- | -- | -- |
| 2026-03-06 | Keenan Greg | officer: SVP, Chief Medical Officer | F-InKind | 8,069 | $14.32 | $116K |
| 2026-02-27 | Donley Matthew Maxwell | officer: Chief Operating Officer | A-Award | 58,160 | -- | -- |
| 2026-03-02 | Donley Matthew Maxwell | officer: Chief Operating Officer | F-InKind | 40,761 | $14.21 | $579K |
| 2026-02-27 | Greenleaf Peter | director, officer: Chief Executive Officer | A-Award | 328,424 | $13.97 | $4.6M |
| 2026-02-27 | TANG KEVIN | director | BUY | 214,839 | $14.12 | $3.0M |
| 2026-02-27 | Miller Joseph M | officer: Chief Financial Officer | A-Award | 95,700 | $13.97 | $1.3M |
| 2026-02-27 | Robertson Stephen P. | officer: EVP, General Counsel | A-Award | 59,090 | -- | -- |
| 2026-03-02 | TANG KEVIN | director | BUY | 83,561 | $14.33 | $1.2M |